<?xml version="1.0" encoding="UTF-8"?>
<compound>
  <id type="integer">345725</id>
  <title nil="true"/>
  <common-name>3-[2-(1h-benzimidazol-2-yl)phenyl]-6-bromo-2-phenylquinazolin-4-one</common-name>
  <description>3-[2-(1h-benzimidazol-2-yl)phenyl]-6-bromo-2-phenylquinazolin-4-one is a chemical compound with the formula C27H17BrN4O. It has an average molecular weight of 493.40 g/mol.</description>
  <cas nil="true"/>
  <pubchem-id>63581</pubchem-id>
  <chemical-formula>C27H17BrN4O</chemical-formula>
  <weight>493.4</weight>
  <appearance nil="true"/>
  <melting-point nil="true"/>
  <boiling-point nil="true"/>
  <density nil="true"/>
  <solubility nil="true"/>
  <specific-gravity nil="true"/>
  <flash-point nil="true"/>
  <vapour-pressure nil="true"/>
  <route-of-exposure nil="true"/>
  <target nil="true"/>
  <mechanism-of-toxicity nil="true"/>
  <metabolism nil="true"/>
  <toxicity nil="true"/>
  <lethaldose nil="true"/>
  <carcinogenicity nil="true"/>
  <use-source nil="true"/>
  <min-risk-level nil="true"/>
  <health-effects nil="true"/>
  <symptoms nil="true"/>
  <treatment nil="true"/>
  <created-at type="dateTime">2026-08-31T08:41:38Z</created-at>
  <updated-at type="dateTime">2026-08-31T08:41:38Z</updated-at>
  <interacting-proteins nil="true"/>
  <wikipedia nil="true"/>
  <uniprot-id nil="true"/>
  <kegg-compound-id nil="true"/>
  <omim-id nil="true"/>
  <chebi-id nil="true"/>
  <biocyc-id nil="true"/>
  <ctd-id nil="true"/>
  <stitch-id nil="true"/>
  <drugbank-id nil="true"/>
  <pdb-id nil="true"/>
  <actor-id nil="true"/>
  <organism nil="true"/>
  <export type="boolean">true</export>
  <metabolizing-proteins nil="true"/>
  <transporting-proteins nil="true"/>
  <moldb-smiles>C1=CC=C(C=C1)C2=NC3=C(C=C(C=C3)Br)C(=O)N2C4=CC=CC=C4C5=NC6=CC=CC=C6N5</moldb-smiles>
  <moldb-formula>C27H17BrN4O</moldb-formula>
  <moldb-inchi>InChI=1S/C27H17BrN4O/c28-18-14-15-21-20(16-18)27(33)32(26(31-21)17-8-2-1-3-9-17)24-13-7-4-10-19(24)25-29-22-11-5-6-12-23(22)30-25/h1-16H,(H,29,30)</moldb-inchi>
  <moldb-inchikey>OBNDROSVNUPHDF-UHFFFAOYSA-N</moldb-inchikey>
  <moldb-average-mass type="decimal" nil="true"/>
  <moldb-mono-mass type="decimal">492.05857</moldb-mono-mass>
  <origin nil="true"/>
  <state nil="true"/>
  <logp>6</logp>
  <hmdb-id nil="true"/>
  <chembl-id nil="true"/>
  <chemspider-id nil="true"/>
  <structure-image-file-name nil="true"/>
  <structure-image-content-type nil="true"/>
  <structure-image-file-size type="integer" nil="true"/>
  <structure-image-updated-at type="dateTime" nil="true"/>
  <biodb-id nil="true"/>
  <synthesis-reference nil="true"/>
  <structure-image-caption nil="true"/>
  <chemdb-id>CHEM341618</chemdb-id>
  <dsstox-id nil="true"/>
  <toxcast-id nil="true"/>
  <stoff-ident-origin nil="true"/>
  <stoff-ident-id nil="true"/>
  <susdat-id nil="true"/>
  <iupac>3-[2-(1h-benzimidazol-2-yl)phenyl]-6-bromo-2-phenylquinazolin-4-one</iupac>
  <moldb-polar-surface-area nil="true"/>
  <moldb-refractivity nil="true"/>
  <moldb-polarizability nil="true"/>
  <moldb-rotatable-bond-count nil="true"/>
  <moldb-acceptor-count nil="true"/>
  <moldb-donor-count nil="true"/>
  <moldb-pka-strongest-acidic nil="true"/>
  <moldb-pka-strongest-basic nil="true"/>
  <moldb-physiological-charge nil="true"/>
  <moldb-number-of-rings nil="true"/>
  <moldb-alogps-logp nil="true"/>
  <moldb-alogps-logs nil="true"/>
  <moldb-alogps-solubility nil="true"/>
  <kingdom>Organic compounds</kingdom>
  <superklass>Organoheterocyclic compounds</superklass>
  <klass>Benzimidazoles</klass>
  <subklass>Phenylbenzimidazoles</subklass>
  <paper-count type="integer" nil="true"/>
  <sync-id>CED0296081</sync-id>
  <structure-inchikey>OBNDROSVNUPHDF-UHFFFAOYSA-N</structure-inchikey>
  <structure-fingerprint>101000000000000080000000000000000000000000040000020000001008000002014000000000000000000400000200080000001000000000000000000000000000020000000000000000000808000000200080000000000000000000000100000000400000100000040000080000001000000000000000000804000200000000004800000000100000000000000000000000100000000000000040000080000000000000000000000000000000000000000000000000000002040000100010000000000000002002020004200000001000000080000000001000040100000000000000000000000000040000000000000</structure-fingerprint>
  <structure-pattern-fingerprint>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</structure-pattern-fingerprint>
  <structure-pickle type="binary" encoding="base64">776t3gAAAAAQAAAAAwAAAAAAAAAhAAAAJgAAAIABBkBoAAAAAwMBBkBoAAAA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</structure-pickle>
  <structure-indexed-at type="dateTime">2026-09-19T05:44:41Z</structure-indexed-at>
</compound>
